111 related articles for article (PubMed ID: 35759244)
1. EBV protection- and susceptibility-related HLA alleles and EBV status in the Chinese population: A single-center study.
Suolitiken D; Wang Y; Jin Z; Wang Z
Immun Inflamm Dis; 2022 Jul; 10(7):e666. PubMed ID: 35759244
[TBL] [Abstract][Full Text] [Related]
2. HLA Allele E*01:01 Is Associated with a Reduced Risk of EBV-Related Classical Hodgkin Lymphoma Independently of HLA-A*01/*02.
Martín P; Krsnik I; Navarro B; Provencio M; García JF; Bellas C; Vilches C; Gomez-Lozano N
PLoS One; 2015; 10(8):e0135512. PubMed ID: 26261988
[TBL] [Abstract][Full Text] [Related]
3. Undifferentiated nasopharyngeal carcinoma from a nonendemic area: protective role of HLA allele products presenting conserved EBV epitopes.
Pasini E; Caggiari L; Dal Maso L; Martorelli D; Guidoboni M; Vaccher E; Barzan L; Franchin G; Gloghini A; De Re V; Sacchi N; Serraino D; Carbone A; Rosato A; Dolcetti R
Int J Cancer; 2009 Sep; 125(6):1358-64. PubMed ID: 19536817
[TBL] [Abstract][Full Text] [Related]
4. Differential cellular targets of Epstein-Barr virus (EBV) infection between acute EBV-associated hemophagocytic lymphohistiocytosis and chronic active EBV infection.
Kasahara Y; Yachie A; Takei K; Kanegane C; Okada K; Ohta K; Seki H; Igarashi N; Maruhashi K; Katayama K; Katoh E; Terao G; Sakiyama Y; Koizumi S
Blood; 2001 Sep; 98(6):1882-8. PubMed ID: 11535525
[TBL] [Abstract][Full Text] [Related]
5. Epstein-Barr virus negativity among individuals older than 60 years is associated with HLA-C and HLA-Bw4 variants and tonsillectomy.
Durovic B; Gasser O; Gubser P; Sigle J; Hirsch HH; Stern M; Buser A; Hess C
J Virol; 2013 Jun; 87(11):6526-9. PubMed ID: 23536655
[TBL] [Abstract][Full Text] [Related]
6. Modeling HLA associations with EBV-positive and -negative Hodgkin lymphoma suggests distinct mechanisms in disease pathogenesis.
Johnson PC; McAulay KA; Montgomery D; Lake A; Shield L; Gallagher A; Little AM; Shah A; Marsh SG; Taylor GM; Jarrett RF
Int J Cancer; 2015 Sep; 137(5):1066-75. PubMed ID: 25648508
[TBL] [Abstract][Full Text] [Related]
7. Systemic Epstein-Barr Virus-Positive T/NK Lymphoproliferative Diseases With
Ishimura M; Eguchi K; Shiraishi A; Sonoda M; Azuma Y; Yamamoto H; Imadome KI; Ohga S
Front Pediatr; 2019; 7():183. PubMed ID: 31231620
[TBL] [Abstract][Full Text] [Related]
8. Gene-environment interactions: Epstein-Barr virus infection and risk of pediatric-onset multiple sclerosis.
Ziaei A; Solomon O; Casper TC; Waltz M; Weinstock-Guttman B; Aaen G; Wheeler Y; Graves J; Benson L; Gorman M; Rensel M; Mar S; Lotze T; Greenberg B; Chitnis T; Waldman AT; Krupp L; James JA; Hart J; Barcellos LF; Waubant E
Mult Scler; 2024 Mar; 30(3):308-315. PubMed ID: 38332747
[TBL] [Abstract][Full Text] [Related]
9. HLA-A alleles and infectious mononucleosis suggest a critical role for cytotoxic T-cell response in EBV-related Hodgkin lymphoma.
Hjalgrim H; Rostgaard K; Johnson PC; Lake A; Shield L; Little AM; Ekstrom-Smedby K; Adami HO; Glimelius B; Hamilton-Dutoit S; Kane E; Taylor GM; McConnachie A; Ryder LP; Sundstrom C; Andersen PS; Chang ET; Alexander FE; Melbye M; Jarrett RF
Proc Natl Acad Sci U S A; 2010 Apr; 107(14):6400-5. PubMed ID: 20308568
[TBL] [Abstract][Full Text] [Related]
10. HLA class I (A, B, C) and class II (DRB1, DQA1, DQB1, DPB1) alleles and haplotypes in the Han from southern China.
Trachtenberg E; Vinson M; Hayes E; Hsu YM; Houtchens K; Erlich H; Klitz W; Hsia Y; Hollenbach J
Tissue Antigens; 2007 Dec; 70(6):455-63. PubMed ID: 17900288
[TBL] [Abstract][Full Text] [Related]
11. HLA-A alleles of patients with pyothorax-associated lymphoma: anti-Epstein-Barr virus (EBV) host immune responses during the development of EBV latent antigen-positive lymphomas.
Kanno H; Ohsawa M; Hashimoto M; Iuchi K; Nakajima Y; Aozasa K
Int J Cancer; 1999 Aug; 82(5):630-4. PubMed ID: 10417757
[TBL] [Abstract][Full Text] [Related]
12. Epstein-barr virus gene expression, human leukocyte antigen alleles and chronic high viral loads in pediatric renal transplant patients.
Moran J; Carr M; Waters A; Boyle S; Riordan M; Connell J; Awan A; Hall W; Hassan J
Transplantation; 2011 Aug; 92(3):328-33. PubMed ID: 21685826
[TBL] [Abstract][Full Text] [Related]
13. Diversities of HLA-A, -B, -C, -DRB1 and -DQB1 loci in Chinese Kazak population and its genetic relatedness dissection with multiple populations: a comparative study.
Wang HD; Jin XY; Yin SS; Zhang Q; Su JX; Shen CM; Zhu BF
Hum Immunol; 2021 Apr; 82(4):215-225. PubMed ID: 33526272
[TBL] [Abstract][Full Text] [Related]
14. HLA alleles modulate EBV viral load in multiple sclerosis.
Agostini S; Mancuso R; Guerini FR; D'Alfonso S; Agliardi C; Hernis A; Zanzottera M; Barizzone N; Leone MA; Caputo D; Rovaris M; Clerici M
J Transl Med; 2018 Mar; 16(1):80. PubMed ID: 29587799
[TBL] [Abstract][Full Text] [Related]
15. HLA expression and HLA type associations in relation to EBV status in Hispanic Hodgkin lymphoma patients.
Fletcher LB; Veenstra RN; Loo EY; Hwang AE; Siddiqi IN; Visser L; Hepkema BG; Nolte IM; van den Berg A; Cozen W; Diepstra A
PLoS One; 2017; 12(3):e0174457. PubMed ID: 28334025
[TBL] [Abstract][Full Text] [Related]
16. A genome-wide integrative genomic study localizes genetic factors influencing antibodies against Epstein-Barr virus nuclear antigen 1 (EBNA-1).
Rubicz R; Yolken R; Drigalenko E; Carless MA; Dyer TD; Bauman L; Melton PE; Kent JW; Harley JB; Curran JE; Johnson MP; Cole SA; Almasy L; Moses EK; Dhurandhar NV; Kraig E; Blangero J; Leach CT; Göring HH
PLoS Genet; 2013; 9(1):e1003147. PubMed ID: 23326239
[TBL] [Abstract][Full Text] [Related]
17. Development and characterization of a cell donor registry for virus-specific T cell manufacture in a blood bank.
Rudilla F; Carrasco-Benso MP; Pasamar H; López-Montañés M; Andrés-Rozas M; Tomás-Marín M; Company D; Moya C; Larrea L; Guerreiro M; Barba P; Arbona C; Querol S
HLA; 2024 Mar; 103(3):e15419. PubMed ID: 38450972
[TBL] [Abstract][Full Text] [Related]
18. HLA Class II alleles and the presence of circulating Epstein-Barr virus DNA in Greek patients with nasopharyngeal carcinoma.
Karanikiotis C; Daniilidis M; Karyotis N; Bakogiannis C; Economopoulos T; Murray S; Papamichael D; Samantas E; Nikolaou A; Skoura L; Tselis N; Zamboglou N; Fountzilas G
Strahlenther Onkol; 2008 Jun; 184(6):325-31. PubMed ID: 18535809
[TBL] [Abstract][Full Text] [Related]
19. HLA-DQ
Li Q; Bu W; Gabriel E; Aguilar F; Hoshino Y; Miyadera H; Hess C; Hornung RL; Roy A; Cohen JI
JCI Insight; 2017 Feb; 2(4):e85687. PubMed ID: 28239644
[TBL] [Abstract][Full Text] [Related]
20. Dominant expression of interleukin-10 and transforming growth factor-beta genes in activated T-cells of chronic active Epstein-Barr virus infection.
Ohga S; Nomura A; Takada H; Tanaka T; Furuno K; Takahata Y; Kinukawa N; Fukushima N; Imai S; Hara T
J Med Virol; 2004 Nov; 74(3):449-58. PubMed ID: 15368517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
